(Q39822325)

14 September 2017

Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model (English)

1 reference

14 September 2017

dasatinib monohydrate

1 reference

1 reference

1 reference

1

1 reference

14 September 2017

Fabiola Sesti

7

0 references

author name string

Camillo Mancini

2

1 reference

14 September 2017

Vincenzo Cesi

3

1 reference

14 September 2017

Barbara Tanno

4

1 reference

14 September 2017

Marta Piscitelli

5

1 reference

14 September 2017

Mariateresa Mancuso

6

1 reference

14 September 2017

Emanuela Pasquali

8

1 reference

14 September 2017

Bruno Calabretta

9

1 reference

14 September 2017

Carlo Dominici

10

1 reference

14 September 2017

Giuseppe Raschellà

11

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

International Journal of Cancer

14 September 2017

1 reference

14 September 2017

125

1 reference

14 September 2017

11

1 reference

14 September 2017

2547-2555

1 reference

Expression and function of TRK-B and BDNF in human neuroblastomas

14 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.24606

In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.

21 January 2018

1 reference

12 December 2020

Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.

1 reference

12 December 2020

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

1 reference

12 December 2020

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

12 December 2020

Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.

1 reference

12 December 2020

Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells

1 reference

12 December 2020

Tyrosine kinases as targets for cancer therapy

1 reference

12 December 2020

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

1 reference

12 December 2020

1 reference

12 December 2020

Initial testing of dasatinib by the pediatric preclinical testing program

1 reference

12 December 2020

Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas

1 reference

12 December 2020

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.

1 reference

12 December 2020

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.

1 reference

12 December 2020

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma

1 reference

12 December 2020

Identification of ALK as a major familial neuroblastoma predisposition gene

1 reference

12 December 2020

Overriding imatinib resistance with a novel ABL kinase inhibitor

1 reference

12 December 2020

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

12 December 2020

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma

1 reference

12 December 2020

Gene amplification in human neuroblastomas: basic mechanisms and clinical implications

1 reference

12 December 2020

Activating mutations in ALK provide a therapeutic target in neuroblastoma

1 reference

12 December 2020

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

1 reference

12 December 2020

A metastatic neuroblastoma model in SCID mice

1 reference

12 December 2020

Oncogenic mutations of ALK kinase in neuroblastoma

1 reference

12 December 2020

Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis

1 reference

12 December 2020

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

1 reference

12 December 2020

Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo

1 reference

12 December 2020

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression

1 reference

12 December 2020

Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition

1 reference

12 December 2020

Neuroblastoma: biological insights into a clinical enigma

1 reference

12 December 2020

Drug resistance and the solid tumor microenvironment

1 reference

12 December 2020

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

1 reference

12 December 2020

1 reference

12 December 2020

The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival.

1 reference

12 December 2020

Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.24606

1 reference

14 September 2017

0 references

1 reference